PHACE SYNDROME
Tracking # 20-1032636
$99999.00
There are no ratings for this course
Learn moreCourse overview
INFANTILE HEMANGIOMA IS THE MOST PREVALENT BENIGN TUMOR OF INFANCY, WITH AN ESTIMATED INCIDENCE BETWEEN 4 AND 5 PERCENT. LARGE FACIAL SEGMENTAL HEMANGIOMA IS ASSOCIATED WITH PHACES SYNDROME, WHICH IS AN ACRONYM FOR POSTERIOR FOSSA MALFORMATIONS, HEMANGIOMA OF THE CERVICOFACIAL REGION, ARTERIAL ANOMALIES, CARDIAC ANOMALIES, EYE ANOMALIES, AND STERNAL OR ABDOMINAL CLEFTING OR ECTOPIA CORDIS. THIS ACTIVITY REVIEWS THE EVALUATION AND MANAGEMENT OF PHACES SYNDROME AND HIGHLIGHTS THE ROLE OF INTERPROFESSIONAL TEAM MEMBERS IN COLLABORATING TO PROVIDE WELL-COORDINATED CARE AND ENHANCE OUTCOMES FOR AFFECTED PATIENTS.
Subject areas
This course counts toward the state boards and subject areas below.